Shahswar, Rabia http://orcid.org/0000-0001-6266-6316
Beutel, Gernot
Gabdoulline, Razif
Koenecke, Christian
Markel, Dominik
Eder, Matthias
Stadler, Michael
Gohring, Gudrun
Schlegelberger, Brigitte
Trummer, Arne
Krauter, Juergen
Thol, Felicitas
Heuser, Michael
Funding for this research was provided by:
DFG (HE 5240/5-2, HE 5240/6-1, HE 5240/6-2)
European Union's Horizon 2020 research and innovation program (638035)
Article History
Received: 17 June 2020
Accepted: 9 July 2020
First Online: 23 July 2020
Compliance with ethical standards
:
: MH reports honoraria from Novartis, Pfizer, and PriME Oncology, a consulting or advisory role for Abbvie, Bayer Pharma AG, Daiichi Sankyo, Novartis, and Pfizer, and research funding to the institution from Abbvie, Astellas, Bayer Pharma AG, BergenBio, Daiichi Sankyo, Karyopharm, Novartis, Pfizer, and Roche. All other authors declare no conflicts of interest. All authors read and agreed to the final version of the manuscript.